FREE Webinar – Treating Mental Illness Through Psychodrama and Ketamine-Assisted Psychotherapy: A Novel Treatment Approach with Dr Bessel van der Kolk (USA) & Dr Gita Vaid (USA) · Mind Medicine Australia
Mind Medicine Australia logo Menu

FREE Webinar – Treating Mental Illness Through Psychodrama and Ketamine-Assisted Psychotherapy: A Novel Treatment Approach with Dr Bessel van der Kolk (USA) & Dr Gita Vaid (USA)

With Dr Bessel Van der Kolk (USA) and Dr Gita Vaid (USA)

Date: Wed 22 November 2023 @ 12:00pm
Location: Webinar (online)

Don’t miss out – Get your tickets early!

Join this FREE WEBINAR presented by Dr Bessel van der Kolk (USA) & Dr Gita Vaid (USA)

TOPIC: Treating Mental Illness Through Psychodrama and Ketamine-Assisted Psychotherapy: A Novel Treatment Approach

Dr Bessel van der Kolk and Dr Gita Vaid will discuss a novel experimentation workshop model to display clinical excellence, educate and raise awareness of psychedelic psychotherapy to treat a range of mental illnesses including trauma, depression, anxiety, addictions and more.

The session will draw from their Psychodrama/Ketamine-Assisted Psychotherapy (KAP) Workshop in 2022, as well as their recent workshop at MAPS’ Psychedelic Science conference. In these workshops they investigated combining these complementary modalities. A clinical laboratory approach was utilized to experiment and display how these treatment approaches might be combined and modified to tailor various elements, reveal psychotherapeutic findings and clinical considerations in a crucible that simulates real-world clinical practice.

In this webinar you will learn about:

  • Psychodrama methodology
  • Concerns raised in considering augmentation with KAP
  • KAP approach, including considerations/questions to be explored in the clinical experiment
  • Sharing footage from psychodrama/KAP workshops


DATE: Wednesday 22 November 2023
TIME: 11:55am (AEDT) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online – a link will be emailed to you with the viewing details

The Presenters

Dr Bessel Van der Kolk (USA)


Bessel van der Kolk MD, Professor of Psychiatry, Boston University School of Medicine and President, Trauma Research Foundation, has spent his career studying how children and adults adapt to traumatic experiences, and have tried to translate emerging findings from pharmacology, neuroscience and attachment research to develop and study potentially effective treatments for traumatic stress in children and adults.

In 1984 he set up one of the first clinical/research centers in the US dedicated to study and treatment of traumatic stress in civilian populations, which has trained numerous researchers and clinicians specializing in the study and treatment of traumatic stress, and which has been continually funded to research the impact of traumatic stress and effective treatment interventions. He conducted the first studies on the effects of SSRIs on PTSD; he was a member of the first neuroimaging team to investigate how trauma changes brain processes, and he did the first research linking BPD and deliberate self-injury to trauma and neglect in early childhood.

Much of his research has focused on how trauma has a different impact at different stages of development, and that disruptions in care-giving systems have additional deleterious effects that need to be addressed for effective intervention. In order to promote a deeper understanding of the impact of childhood trauma and to foster the development and execution of effective treatment interventions he initiated the process that led to the establishment of the National Child Traumatic Stress Network (NCTSN), a Congressionally mandated initiative that now funds approximately 150 centers specializing in developing effective treatment interventions, and implementing them in a wide array of settings, from juvenile detention centers to tribal agencies, nationwide. He has focused on studying treatments that stabilize physiology, increase executive functioning and help traumatized individuals to feel fully alert to the present. This has included an NIMH funded study on EMDR and NCCAM funded study of yoga, and, in recent years, the study of neurofeedback to investigate whether attentional and perceptual systems (and the neural tracks responsible for them) can be altered by changing EEG patterns.

Currently he is Principal Investigator of the Boston arm of the MAPS 1 and 2 studies on the effects of MDMA on people with chronic PTSD. His seminal book The Body keeps the Score , has been on the New York Times best seller list for over 230 weeks, and has been translated into 42 different languages.

Dr Gita Vaid (USA)


Gita Vaid MD is a board certified psychiatrist and psychoanalyst a co-founder of the Center for Natural Intelligence, a multidisciplinary laboratory dedicated to psychedelic psychotherapy innovation and clinical practice. A lead instructor at The Ketamine Training Center and member of the Mount Sinai Psychedelic Psychotherapy Research and Trauma Center, she is a Multidisciplinary Association for Psychedelic (MAPS)  – trained psychedelic psychotherapist practicing ketamine assisted psychotherapy in New York City. Dr Vaid completed her psychiatry residency training at NYU Medical Center and psychoanalytic training at the Psychoanalytic Association of New York. She trained as a Fellow in clinical psychopharmacology and neurophysiology at New York Medical College and completed a research fellowship at NYU Medical Center. Dr Vaid serves as the Director of Psychedelic Awareness at The Chopra Foundation.

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia: